Skip Navigation
Skip to contents

J Korean Diabetes.  2016 Jun;17(2):83-87. 10.4093/jkd.2016.17.2.83.

Clinical Practice Guideline 2015: Oral Hypoglycemic Agents for Patients with Type 2 Diabetes

Affiliations
  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, College of of Medicine, The Catholic University of Korea, Seoul, Korea. kosh@catholic.ac.kr

Abstract

The revised Clinical Practice Guideline (5th edition) for patients with diabetes was released in November 2015 by the Korean Diabetes Association. Strict glycemic control is emphasized for the prevention and progression of diabetes-related vascular complications. The recommended target goal of HbA1c is less than 6.5%, especially for patients with recently diagnosed type 2 diabetes. To achieve this target goal, various classes of oral hypoglycemic agents and insulin should be initiated promptly, according to the patient's clinical situation. Accurate and up-to-date information about the available oral hypoglycemic agents will help increase glycemic control and diabetes management.

Keyword

Diabetes mellitus type 2; Hypoglycemic agents; Treatment guideline

MeSH Terms

Humans
Hypoglycemic Agents*
Insulin
Hypoglycemic Agents
Insulin
Full Text Links
  • JKD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr